Peter has over three decades of experience in the pharmaceutical and biotechnology sectors. At Syngene, he is responsible for strategy and execution, steering the investment decisions, leading the executive team and the Company’s business operations.

Peter has extensive global experience in strategic and operational leadership including at the Board, CEO and Senior Corporate Leadership levels. He has an extensive track record of success in building companies, businesses, teams, and brands. His experience in biopharmaceuticals straddles business and technology segments (biotechnology, vaccines, branded generics, life sciences, CRO) and geographies encompassing both advanced and emerging markets.

Peter served as CEO of Sosei Group (now Nxera Pharma), a Japanese listed biopharmaceutical company. Prior to this, Peter worked with GlaxoSmithKline over a period of 23 years, where he held several roles including Head of Global Marketing and Senior Vice President of commercial development for GSK’s international regions.

Peter also served as CEO and on the Board of Syngene for almost six years starting 2010 and led the company to its successful public listing in 2015.

Peter holds a bachelor’s degree in science (combined honours in Zoology and Physiology) from the University of Sheffield, UK.